Changes in fibrinolysis in the intensive care patient
LJG Frade, L Landin, AG Avello, JM Yerro… - Thrombosis research, 1987 - Elsevier
Critically ill patients have been described as having blood coagulation abnormalities that
predispose to bleeding and thrombosis. We have studied plasminogen activators. α-
antiplasmin, X-oligomers fibrin fragments, fibronectin, antithrombin III, fibrinogen, platelets,
kaolin-cephalin clotting time and prothrombin time on admission to the intensive care unit
and sequentially after 24 and 48 hours in 39 adult patients: ARDS (n= 6), trauma (n= 12),
sepsis (n= 8) and a miscellanea (n= 13) A decrease in plasminogen activators associated …
predispose to bleeding and thrombosis. We have studied plasminogen activators. α-
antiplasmin, X-oligomers fibrin fragments, fibronectin, antithrombin III, fibrinogen, platelets,
kaolin-cephalin clotting time and prothrombin time on admission to the intensive care unit
and sequentially after 24 and 48 hours in 39 adult patients: ARDS (n= 6), trauma (n= 12),
sepsis (n= 8) and a miscellanea (n= 13) A decrease in plasminogen activators associated …